Back to medications
Medication monograph
lisocabtagene maraleucel
Chimeric Antigen Receptor T-cell (CAR-T) TherapyImmunotherapy AgentsCD19-Directed Genetically Modified Autologous T-cell Immunotherapies
Clinical reference
Product monograph
BREYANZI- lisocabtagene maraleucel kit
Brands & formulations
Family members
BREYANZI
Marketed120000000 CELLSINTRAVENOUSSUSPENSION[
"lisocabtagene maraleucel"
]
Product monograph Classification
- Chemical class
- Chimeric Antigen Receptor T-cell (CAR-T) Therapy
- Clinical class
- Immunotherapy Agents
- Banks class
- CD19-Directed Genetically Modified Autologous T-cell Immunotherapies